I see the bogus concerns of time constraints for G

Quote:

---

I see the bogus concerns of time constraints for GC as a non-issue, and as referenced earlier, a positive...again, for AMBS. Really it doesn't take an "expert" to do the math lol...

---

You are taking what I wrote out context. I have no idea what involvement Gerald will have with this lobbying outfit in DC. It's why I am asking for clarification of what it entails. Remember, most of this takes place in D.C. where Bio is headquartered. I just find this news odd as Gerald has a fledgling company to run. Again, I think it's a legitimate concern to have because the PR explained absolutely nothing about how Gerald is going to juggle this while we await the launch of Lympro. So if Gerald comes out and states this won't take very much of his time, then that's fine with me. But you nor I know squat about what his involvement will be.

My Agenda: To see Amarantus prosper so I can make a nice return on my investment.